Press Releases

Greenphire Launches Extension of its ConneX Solution, ConneX Patient Direct, as Trial Sites Seek Support in Response to COVID-19

Clinical Ink Donates Mobile Devices to Aid in Mental Tele-Health

Clinical Ink, a global clinical trial technology company, has made a commitment to donate several hundred mobile phones and tablets to Thrive Behavioral Health for individual and family mental tele-health services, which are largely replacing in-person sessions during the COVID-19 crisis.

Clinically-proven gamification app teaches positive inhaler technique; crucial for managing asthma

A newly validated app called Rafi-Tone, developed by clinicians in the UK, makes using an inhaler with a spacer easier and more fun for young children with wheeze or asthma symptoms.

Biological Specialty Company Launches At-home Blood Donation Service for COVID-19 Patients Who Want to Help Develop New Drugs and Vaccines

BSC is collecting blood samples from sick and recovered COVID-19 patients to assist in developing COVID-19 therapies, vaccines and diagnostic biomarkers.

ERT’s At-Home Cardiac Safety Assessment Ensures Clinical Trial Continuity

Company’s expertise, infrastructure and flexibility enable remote ECG assessment for fast-tracked COVID-19 vaccines /therapies and other critical pharmaceuticals

CD Bioparticles Announces Carbon-based Nanocages Production Services for Researchers

CD Bioparticles introduces carbon-based nanocages production services to global researchers.

PHARMASEAL Supports Life Science Businesses by Offering No Cost CTMS for COVID-19 Clinical Trials

PHARMASEAL International, provider of clinical trials management systems has today announced that it will offer the Engility® CTMS solution at no cost for COVID-19 Coronavirus clinical trials. The free offer to utilize Engility CTMS is open to biopharmaceutical organizations and academic institutions.

ERT Enables Clinical Trial Continuity through At-Home Respiratory Solutions

High-quality clinician-administered data collected during patient home visits advances respiratory trials throughout COVID-19 pandemic

Serimmune Announces Achievement of Research Milestone in Discovery and Development Collaboration with Merck

Serimmune, a leader in understanding the functional antibody repertoire’s role in human disease, today announced that the company has received a research milestone payment from Merck (known as MSD outside the United States and Canada) under its ongoing discovery and development collaboration agreement.

Zymewire Launches Directory Of Drug Development Experts With Services Available To Fight COVID-19

Zymewire announces the launch of CovidCollaborators.org, an online directory of expert, pro-bono, and discounted clinical development services being offered in the fight against COVID-19.

Noxopharm Investigating Potential COVID-19 Treatment

Noxopharm has identified a clinical trial opportunity that could help reduce the mortality rate of COVID-19.

FHI CLINICAL PROVIDING FULL-SERVICE CRO CAPABILITIES FOR CORONAVIRUS (COVID-19) CLINICAL TRIAL

FHI Clinical just announced it has partnered with Seattle-based Infectious Disease Research Institute (IDRI) to provide full-service CRO capabilities for an immunotherapy trial to combat moderate to severe cases of COVID-19.

OBVIOHEALTH LAUNCHES VIRTUAL COVID-19 SYMPTOMS & IMMUNE RESPONSE REGISTRY

Spring Bank Provides Update on Business Operations & Clinical Program Progress During COVID-19 Pandemic

The release announces an update on the company’s business operations in response to and as a result of the global COVID-19 pandemic; one of the announcements includes the Safety Review Committee for IV SB 11285 Phase 1a/1b trial recommends dose escalation to next planned dose level.

WCG Launches Program to Provide Clinical Research Professionals with Timely Information During the COVID-19 Pandemic

The initiative launches with a weekly webinar series featuring WCG experts and guest panelists, with a focus on communicating emerging best practices in real time.

CluePoints´ Central Statistical Monitoring Supports Business Continuity as Coronavirus Impacts Clinical Trial Operations

CluePoints, the premier provider of Risk-Based Trial Execution (RBx) and Data Quality Oversight Software for clinical trials, today announced that it has seen a dramatic increase in demand for remote and centralized site monitoring amid the ongoing Coronavirus outbreak.

Albumedix Announces CBER FDA Drug Master File Acceptance for Recombumin® Elite and Appointment of Director of Regulatory Affairs

Creative Diagnostics Now Launches New Plant Pathogens Antibodies for Research Use

Creative Diagnostics launches high-quality plant pathogens antibodies for use in ELISA or related immunoassays.

Rho Experts Share Best Practices for Managing Risks in Clinical Trials

Rho, a full-service contract research organization (CRO) that helps pharmaceutical and biotechnology companies bring their products to market through high-quality clinical research services, will outline and provide tips on the U.S. Food and Drug Administration (FDA)’s new sponsor responsibilities for managing risks in clinical trials in an upcoming webinar, “Managing the Risks of Implementing E6R2.” The webinar will take place on Wednesday, March 25, from 1-2 p.m. EST.

COVID-19 RAPID DETECTION – ICENI DIAGNOSTICS OFFERS NEW APPROACH

Coronavirus could be detected using Iceni Diagnostics’ rapid, point-of-care screening technology, and distinguish between different viral strains